Prot #IM027068: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IPF)

Project: Research project

Project Details

StatusActive
Effective start/end date2/23/242/23/27

Funding

  • Fortrea, Inc. (Prot #IM027068 // Prot #IM027068)
  • Bristol-Myers Squibb Company (Prot #IM027068 // Prot #IM027068)